{"disease":{"id":"hlh","name":"hlh"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06768008","title":"An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT05882175","title":"Prospective Validation of the OHI Index","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT04758650","title":"Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT06899581","title":"Gut Health in Children With Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false},{"nct_id":"NCT05063110","title":"Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04644016","title":"Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06951971","title":"Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT02472054","title":"Treatment of Familiar Lymphohistiocytosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07295730","title":"3D Modalities for Medical Student Education of Congenital Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT07525466","title":"Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT07531069","title":"Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06048107","title":"Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05258136","title":"Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT05320575","title":"Zanubrutinib for HLH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03525418","title":"Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Longeveron Inc.","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}